Original Research
Published on 07 Nov 2024
Rabeprazole suppressed gastric intestinal metaplasia through activation of GPX4-mediated ferroptosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1409001
Type at least 3 characters
1,080 articles
Articles
Original Research
Accepted on 05 Nov 2024
Integrated multi-omics analyses discovered that cis-TSG alleviated liver injury via modulating lipid metabolism
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485035
- 121 views
Original Research
Published on 05 Nov 2024
Mex3a promoter hypomethylation can be utilized to diagnose HBV-associated hepatocellular carcinoma: a randomized controlled trial
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1325869
- 100 views
Original Research
Accepted on 04 Nov 2024
p-hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448863
Original Research
Accepted on 01 Nov 2024
Tracing the historical foundations of infliximab in Crohn's Disease treatment: a cited reference analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1498464
Original Research
Accepted on 01 Nov 2024
Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1461398
Clinical Trial
Accepted on 28 Oct 2024
Comparison of Enteral Prucalopride versus Intravenous Metoclopramide for Feeding Intolerance in Patients with Critical Illness: A Randomized Double-blinded Study
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413246
Original Research
Published on 28 Oct 2024
Modulation of Notch signaling pathway in activated hepatic stellate cells does not ameliorate the outcome of liver fibrosis in carbon tetrachloride and DDC-feeding models
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1440236
- 132 views
Original Research
Accepted on 25 Oct 2024
Celecoxib and rofecoxib have different effect on small intestinal ischemia/reperfusion injury in rats
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468579
Review
Published on 24 Oct 2024
Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485065
- 264 views
Original Research
Published on 24 Oct 2024
Multi-omics reveals the alleviating effect of berberine on ulcerative colitis through modulating the gut microbiome and bile acid metabolism in the gut-liver axis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1494210
- 169 views
Review
Accepted on 22 Oct 2024
Alcohol-related Liver Disease (ALD): Current perspectives on pathogenesis, therapeutic strategies, and animal models
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1432480
Original Research
Published on 22 Oct 2024
GYY4137, as a slow-releasing H2S donor, ameliorates sodium deoxycholate–induced chronic intestinal barrier injury and gut microbiota dysbiosis
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476407
- 180 views
Systematic Review
Published on 17 Oct 2024
Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: a network meta-analysis of randomized controlled trials
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430724
- 510 views
Original Research
Published on 16 Oct 2024
Effectiveness of biologic therapies in achieving treatment targets in inflammatory bowel disease; real-world data from the Middle East (ENROLL study)
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1388043
- 399 views
Review
Published on 16 Oct 2024
Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1464655
- 446 views